Bradley Gillespie, PharmD, trained as a clinical pharmacist and has practiced in an industrial setting for the past 20-plus years. His initial role was clinical pharmacology and biopharmaceutics reviewer at the FDA, followed by 15 years of leading early development programs in the pharma/biotech/nutritional industries. Currently, he supports efforts at the National Institutes of Health to develop therapeutics for rare and neglected diseases. In addition to his industrial focus, he remains a registered pharmacist and operates a medical writing business, with a focus on developing health professional continuing education programs.